Clinical Trials on Diabetes
Clinical trials is an advanced way to carry out research work and simultaneously improving the medical care of type 2 diabetic patient. Different trials around the globe is being carried out in development of cost effective technology to cure diabetes.
U.S Trials
Type 1 Diabetes - Recent trial is being carried out by ViaCyte Inc. which is a private organization in regenerative medicine. The organization has launched first phase of clinical trial for a stem-cell deficient product patient(VC-01™) and developed by us of two novel technologies : stem cell combined with novel delivery device called Encaptra® used to deliver a dose of cells in different body locations.
Type 2 Diabetes - This research work is NIH-funded for type 2 diabetes and focuses on diabetic patients who rely on metformin medication. The trial name is GRADE. The main purpose is to find an optimal combination of diabetic drugs for optimal glycemic control for prolong treatment of type 2 diabetes populations.
U.K Trials
Type 1 Diabetes - A collaborative U.K research team for the first time is using a peptide with memory to for testing the safety of type 1 vaccine.
Type 2 Diabetes - A French organization Pharmaleads for the first time will be carrying out investigation to know the potential level of a novel have ability to cure diabetic neuropathy.